ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Commercial Drug Manufacturing Service Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-33O18713
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Commercial Drug Manufacturing Service Market Research Report 2025
BUY CHAPTERS

Global Commercial Drug Manufacturing Service Market Research Report 2025

Code: QYRE-Auto-33O18713
Report
January 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Almac Group
Piramal Pharma
ALTASCIENCES
UPM Pharmaceuticals
Aphena Pharma Solutions
Quotient Sciences
Thermo Fisher Scientific
PCI
Experic
Carbogen-Amcis
AbbVie
Alcami
Lonza
Pyramid Labs
Torbay Pharma

Commercial Drug Manufacturing Service Market Size

The global market for Commercial Drug Manufacturing Service was valued at US$ 1836 million in the year 2024 and is projected to reach a revised size of US$ 2674 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Commercial Drug Manufacturing Service Market

Commercial Drug Manufacturing Service Market

Commercial drug manufacturing service refers to a series of manufacturing services provided to pharmaceutical companies or research institutions, covering the entire process from drug raw material processing to final product packaging. These services encompass various aspects of drug production, including raw material procurement and inspection, drug formula design and optimization, formulation production and quality control, as well as product packaging and labeling. Commercial Drug Manufacturing Services typically adhere to strict production standards and quality control systems to ensure that the produced drugs meet relevant regulatory requirements and quality standards. Furthermore, these services offer flexible production capabilities and the ability to quickly respond to market changes, helping pharmaceutical companies rapidly launch new drugs or improve existing products to meet market demands. Through Commercial Drug Manufacturing Services, pharmaceutical companies can reduce costs, improve efficiency, and focus on core businesses such as drug research and development and market expansion.
North American market for Commercial Drug Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Commercial Drug Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Commercial Drug Manufacturing Service in Tablet is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Commercial Drug Manufacturing Service include Pyramid Labs, Almac Group, Piramal Pharma, Altasciences, UPM Pharmaceuticals, Aphena Pharma Solutions, Quotient Sciences, Thermo Fisher Scientific, PCI, Torbay Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Commercial Drug Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercial Drug Manufacturing Service.
The Commercial Drug Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Commercial Drug Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Commercial Drug Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Commercial Drug Manufacturing Service Market Report

Report Metric Details
Report Name Commercial Drug Manufacturing Service Market
Accounted market size in year US$ 1836 million
Forecasted market size in 2031 US$ 2674 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Tablet
  • Capsule
  • Inhalation Drug
  • Biologics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pyramid Labs, Almac Group, Piramal Pharma, Altasciences, UPM Pharmaceuticals, Aphena Pharma Solutions, Quotient Sciences, Thermo Fisher Scientific, PCI, Torbay Pharma, Experic, Carbogen-Amcis, AbbVie, Alcami, Lonza
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Commercial Drug Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Commercial Drug Manufacturing Service Market growing?

Ans: The Commercial Drug Manufacturing Service Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Commercial Drug Manufacturing Service Market size in 2031?

Ans: The Commercial Drug Manufacturing Service Market size in 2031 will be US$ 2674 million.

Who are the main players in the Commercial Drug Manufacturing Service Market report?

Ans: The main players in the Commercial Drug Manufacturing Service Market are Pyramid Labs, Almac Group, Piramal Pharma, Altasciences, UPM Pharmaceuticals, Aphena Pharma Solutions, Quotient Sciences, Thermo Fisher Scientific, PCI, Torbay Pharma, Experic, Carbogen-Amcis, AbbVie, Alcami, Lonza

What are the Application segmentation covered in the Commercial Drug Manufacturing Service Market report?

Ans: The Applications covered in the Commercial Drug Manufacturing Service Market report are Tablet, Capsule, Inhalation Drug, Biologics, Others

What are the Type segmentation covered in the Commercial Drug Manufacturing Service Market report?

Ans: The Types covered in the Commercial Drug Manufacturing Service Market report are Small Batch Manufacturing Services, Large-Scale Manufacturing Services

Recommended Reports

Drug Development Services

Drug Testing Solutions

Manufacturing & Contract

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Batch Manufacturing Services
1.2.3 Large-Scale Manufacturing Services
1.3 Market by Application
1.3.1 Global Commercial Drug Manufacturing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Inhalation Drug
1.3.5 Biologics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Commercial Drug Manufacturing Service Market Perspective (2020-2031)
2.2 Global Commercial Drug Manufacturing Service Growth Trends by Region
2.2.1 Global Commercial Drug Manufacturing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Commercial Drug Manufacturing Service Historic Market Size by Region (2020-2025)
2.2.3 Commercial Drug Manufacturing Service Forecasted Market Size by Region (2026-2031)
2.3 Commercial Drug Manufacturing Service Market Dynamics
2.3.1 Commercial Drug Manufacturing Service Industry Trends
2.3.2 Commercial Drug Manufacturing Service Market Drivers
2.3.3 Commercial Drug Manufacturing Service Market Challenges
2.3.4 Commercial Drug Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Commercial Drug Manufacturing Service Players by Revenue
3.1.1 Global Top Commercial Drug Manufacturing Service Players by Revenue (2020-2025)
3.1.2 Global Commercial Drug Manufacturing Service Revenue Market Share by Players (2020-2025)
3.2 Global Commercial Drug Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Commercial Drug Manufacturing Service Revenue
3.4 Global Commercial Drug Manufacturing Service Market Concentration Ratio
3.4.1 Global Commercial Drug Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Commercial Drug Manufacturing Service Revenue in 2024
3.5 Global Key Players of Commercial Drug Manufacturing Service Head office and Area Served
3.6 Global Key Players of Commercial Drug Manufacturing Service, Product and Application
3.7 Global Key Players of Commercial Drug Manufacturing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Commercial Drug Manufacturing Service Breakdown Data by Type
4.1 Global Commercial Drug Manufacturing Service Historic Market Size by Type (2020-2025)
4.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2026-2031)
5 Commercial Drug Manufacturing Service Breakdown Data by Application
5.1 Global Commercial Drug Manufacturing Service Historic Market Size by Application (2020-2025)
5.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Commercial Drug Manufacturing Service Market Size (2020-2031)
6.2 North America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
6.4 North America Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Commercial Drug Manufacturing Service Market Size (2020-2031)
7.2 Europe Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
7.4 Europe Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Commercial Drug Manufacturing Service Market Size (2020-2031)
8.2 Asia-Pacific Commercial Drug Manufacturing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Commercial Drug Manufacturing Service Market Size (2020-2031)
9.2 Latin America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
9.4 Latin America Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Commercial Drug Manufacturing Service Market Size (2020-2031)
10.2 Middle East & Africa Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pyramid Labs
11.1.1 Pyramid Labs Company Details
11.1.2 Pyramid Labs Business Overview
11.1.3 Pyramid Labs Commercial Drug Manufacturing Service Introduction
11.1.4 Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.1.5 Pyramid Labs Recent Development
11.2 Almac Group
11.2.1 Almac Group Company Details
11.2.2 Almac Group Business Overview
11.2.3 Almac Group Commercial Drug Manufacturing Service Introduction
11.2.4 Almac Group Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.2.5 Almac Group Recent Development
11.3 Piramal Pharma
11.3.1 Piramal Pharma Company Details
11.3.2 Piramal Pharma Business Overview
11.3.3 Piramal Pharma Commercial Drug Manufacturing Service Introduction
11.3.4 Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.3.5 Piramal Pharma Recent Development
11.4 Altasciences
11.4.1 Altasciences Company Details
11.4.2 Altasciences Business Overview
11.4.3 Altasciences Commercial Drug Manufacturing Service Introduction
11.4.4 Altasciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.4.5 Altasciences Recent Development
11.5 UPM Pharmaceuticals
11.5.1 UPM Pharmaceuticals Company Details
11.5.2 UPM Pharmaceuticals Business Overview
11.5.3 UPM Pharmaceuticals Commercial Drug Manufacturing Service Introduction
11.5.4 UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.5.5 UPM Pharmaceuticals Recent Development
11.6 Aphena Pharma Solutions
11.6.1 Aphena Pharma Solutions Company Details
11.6.2 Aphena Pharma Solutions Business Overview
11.6.3 Aphena Pharma Solutions Commercial Drug Manufacturing Service Introduction
11.6.4 Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.6.5 Aphena Pharma Solutions Recent Development
11.7 Quotient Sciences
11.7.1 Quotient Sciences Company Details
11.7.2 Quotient Sciences Business Overview
11.7.3 Quotient Sciences Commercial Drug Manufacturing Service Introduction
11.7.4 Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.7.5 Quotient Sciences Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Commercial Drug Manufacturing Service Introduction
11.8.4 Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 PCI
11.9.1 PCI Company Details
11.9.2 PCI Business Overview
11.9.3 PCI Commercial Drug Manufacturing Service Introduction
11.9.4 PCI Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.9.5 PCI Recent Development
11.10 Torbay Pharma
11.10.1 Torbay Pharma Company Details
11.10.2 Torbay Pharma Business Overview
11.10.3 Torbay Pharma Commercial Drug Manufacturing Service Introduction
11.10.4 Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.10.5 Torbay Pharma Recent Development
11.11 Experic
11.11.1 Experic Company Details
11.11.2 Experic Business Overview
11.11.3 Experic Commercial Drug Manufacturing Service Introduction
11.11.4 Experic Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.11.5 Experic Recent Development
11.12 Carbogen-Amcis
11.12.1 Carbogen-Amcis Company Details
11.12.2 Carbogen-Amcis Business Overview
11.12.3 Carbogen-Amcis Commercial Drug Manufacturing Service Introduction
11.12.4 Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.12.5 Carbogen-Amcis Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Commercial Drug Manufacturing Service Introduction
11.13.4 AbbVie Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.13.5 AbbVie Recent Development
11.14 Alcami
11.14.1 Alcami Company Details
11.14.2 Alcami Business Overview
11.14.3 Alcami Commercial Drug Manufacturing Service Introduction
11.14.4 Alcami Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.14.5 Alcami Recent Development
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Commercial Drug Manufacturing Service Introduction
11.15.4 Lonza Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.15.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Almac Group
Piramal Pharma
ALTASCIENCES
UPM Pharmaceuticals
Aphena Pharma Solutions
Quotient Sciences
Thermo Fisher Scientific
PCI
Experic
Carbogen-Amcis
AbbVie
Alcami
Lonza
Pyramid Labs
Torbay Pharma
List of Tables
 Table 1. Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Small Batch Manufacturing Services
 Table 3. Key Players of Large-Scale Manufacturing Services
 Table 4. Global Commercial Drug Manufacturing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Commercial Drug Manufacturing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Commercial Drug Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Commercial Drug Manufacturing Service Market Share by Region (2020-2025)
 Table 8. Global Commercial Drug Manufacturing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Commercial Drug Manufacturing Service Market Share by Region (2026-2031)
 Table 10. Commercial Drug Manufacturing Service Market Trends
 Table 11. Commercial Drug Manufacturing Service Market Drivers
 Table 12. Commercial Drug Manufacturing Service Market Challenges
 Table 13. Commercial Drug Manufacturing Service Market Restraints
 Table 14. Global Commercial Drug Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Commercial Drug Manufacturing Service Market Share by Players (2020-2025)
 Table 16. Global Top Commercial Drug Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Drug Manufacturing Service as of 2024)
 Table 17. Ranking of Global Top Commercial Drug Manufacturing Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Commercial Drug Manufacturing Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Commercial Drug Manufacturing Service, Headquarters and Area Served
 Table 20. Global Key Players of Commercial Drug Manufacturing Service, Product and Application
 Table 21. Global Key Players of Commercial Drug Manufacturing Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Commercial Drug Manufacturing Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Commercial Drug Manufacturing Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Commercial Drug Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pyramid Labs Company Details
 Table 47. Pyramid Labs Business Overview
 Table 48. Pyramid Labs Commercial Drug Manufacturing Service Product
 Table 49. Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 50. Pyramid Labs Recent Development
 Table 51. Almac Group Company Details
 Table 52. Almac Group Business Overview
 Table 53. Almac Group Commercial Drug Manufacturing Service Product
 Table 54. Almac Group Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 55. Almac Group Recent Development
 Table 56. Piramal Pharma Company Details
 Table 57. Piramal Pharma Business Overview
 Table 58. Piramal Pharma Commercial Drug Manufacturing Service Product
 Table 59. Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 60. Piramal Pharma Recent Development
 Table 61. Altasciences Company Details
 Table 62. Altasciences Business Overview
 Table 63. Altasciences Commercial Drug Manufacturing Service Product
 Table 64. Altasciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 65. Altasciences Recent Development
 Table 66. UPM Pharmaceuticals Company Details
 Table 67. UPM Pharmaceuticals Business Overview
 Table 68. UPM Pharmaceuticals Commercial Drug Manufacturing Service Product
 Table 69. UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 70. UPM Pharmaceuticals Recent Development
 Table 71. Aphena Pharma Solutions Company Details
 Table 72. Aphena Pharma Solutions Business Overview
 Table 73. Aphena Pharma Solutions Commercial Drug Manufacturing Service Product
 Table 74. Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 75. Aphena Pharma Solutions Recent Development
 Table 76. Quotient Sciences Company Details
 Table 77. Quotient Sciences Business Overview
 Table 78. Quotient Sciences Commercial Drug Manufacturing Service Product
 Table 79. Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 80. Quotient Sciences Recent Development
 Table 81. Thermo Fisher Scientific Company Details
 Table 82. Thermo Fisher Scientific Business Overview
 Table 83. Thermo Fisher Scientific Commercial Drug Manufacturing Service Product
 Table 84. Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 85. Thermo Fisher Scientific Recent Development
 Table 86. PCI Company Details
 Table 87. PCI Business Overview
 Table 88. PCI Commercial Drug Manufacturing Service Product
 Table 89. PCI Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 90. PCI Recent Development
 Table 91. Torbay Pharma Company Details
 Table 92. Torbay Pharma Business Overview
 Table 93. Torbay Pharma Commercial Drug Manufacturing Service Product
 Table 94. Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 95. Torbay Pharma Recent Development
 Table 96. Experic Company Details
 Table 97. Experic Business Overview
 Table 98. Experic Commercial Drug Manufacturing Service Product
 Table 99. Experic Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 100. Experic Recent Development
 Table 101. Carbogen-Amcis Company Details
 Table 102. Carbogen-Amcis Business Overview
 Table 103. Carbogen-Amcis Commercial Drug Manufacturing Service Product
 Table 104. Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 105. Carbogen-Amcis Recent Development
 Table 106. AbbVie Company Details
 Table 107. AbbVie Business Overview
 Table 108. AbbVie Commercial Drug Manufacturing Service Product
 Table 109. AbbVie Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 110. AbbVie Recent Development
 Table 111. Alcami Company Details
 Table 112. Alcami Business Overview
 Table 113. Alcami Commercial Drug Manufacturing Service Product
 Table 114. Alcami Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 115. Alcami Recent Development
 Table 116. Lonza Company Details
 Table 117. Lonza Business Overview
 Table 118. Lonza Commercial Drug Manufacturing Service Product
 Table 119. Lonza Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
 Table 120. Lonza Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Commercial Drug Manufacturing Service Picture
 Figure 2. Global Commercial Drug Manufacturing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Commercial Drug Manufacturing Service Market Share by Type: 2024 VS 2031
 Figure 4. Small Batch Manufacturing Services Features
 Figure 5. Large-Scale Manufacturing Services Features
 Figure 6. Global Commercial Drug Manufacturing Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Commercial Drug Manufacturing Service Market Share by Application: 2024 VS 2031
 Figure 8. Tablet Case Studies
 Figure 9. Capsule Case Studies
 Figure 10. Inhalation Drug Case Studies
 Figure 11. Biologics Case Studies
 Figure 12. Others Case Studies
 Figure 13. Commercial Drug Manufacturing Service Report Years Considered
 Figure 14. Global Commercial Drug Manufacturing Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Commercial Drug Manufacturing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Commercial Drug Manufacturing Service Market Share by Region: 2024 VS 2031
 Figure 17. Global Commercial Drug Manufacturing Service Market Share by Players in 2024
 Figure 18. Global Top Commercial Drug Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Drug Manufacturing Service as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Commercial Drug Manufacturing Service Revenue in 2024
 Figure 20. North America Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
 Figure 22. United States Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
 Figure 26. Germany Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Commercial Drug Manufacturing Service Market Share by Region (2020-2031)
 Figure 34. China Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
 Figure 42. Mexico Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
 Figure 46. Turkey Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Pyramid Labs Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 50. Almac Group Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 51. Piramal Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 52. Altasciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 53. UPM Pharmaceuticals Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 54. Aphena Pharma Solutions Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 55. Quotient Sciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 57. PCI Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 58. Torbay Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 59. Experic Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 60. Carbogen-Amcis Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 61. AbbVie Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 62. Alcami Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 63. Lonza Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Clinical Trial Manufacturing Service Market Research Report 2025
Global Drug Safety Testing Market Research Report 2025
Global Pharmaceutical Characterization Service Market Research Report 2025
Global Pharmaceutical CMO Services Market Research Report 2024
Global Nanomedicine Development and Manufacturing Services Market Research Report 2025
Global Drug Particle Engineering Service Market Research Report 2025
Global Pharmaceutical Serialisation Services Market Research Report 2025
Pharmaceutical Contract Manufacturing and Contract Market
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global Contract Pharmaceutical Manufacturing Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Biopharmaceutical CMO Services Market Research Report 2024
Global Generic Drug Research and Development Services Market Research Report 2024
Global Innovative Drug Commercialization Service Platform Market Research Report 2024
Global Pharmaceutical Manufacturing and Processing Equipment Market Research Report 2024
Healthcare Contract Development And Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug and Medical Device Testing Services Market Research Report 2024
Global ADC Manufacturing Service Market Research Report 2025
Global Pharmaceutical Analytical Service Market Research Report 2025
Global Pharmaceutical Testing Services Market Research Report 2025
Global Pharmaceutical Distribution Service Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions